hydroxyvalerenic acid
2-propenoic acid, 3-[(1R,4S,7R,7aR)-2,4,5,6,7,7a-hexahydro-1-hydroxy-3,7-dimethyl-1H-inden-4-yl]-2-methyl-, (2E)-
Identification
| Name | hydroxyvalerenic acid |
| CAS Number | 1619-16-5 |
| FDA UNII | 043W90DL5F |
| Molecular Formula | C15 H22 O3 |
| Molecular Weight | 250.33794000 |
| Nikkaji Number | J14.962D |
| Beilstein | 2981421 |
Regulatory
Physical Properties
| Assay | 95.00 to 100.00 |
| Food Chemicals Codex Listed | No |
| Boiling Point | 426.00 °C. @ 760.00 mm Hg (est) |
| Flash Point | 438.00 °F. TCC ( 225.60 °C. ) (est) |
| logP (o/w) | 3.293 (est) |
| Soluble in | water, 178.8 mg/L @ 25 °C (est) |
No sensory data available
Safety Information
| Oral/Parenteral Toxicity | Not determined |
| Dermal Toxicity | Not determined |
| Inhalation Toxicity | Not determined |
GHS Classification
['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']
Safety in Use
| Category | natural substances and extractives |
| Recommendation for hydroxyvalerenic acid usage levels up to | not for fragrance use. |
| Recommendation for hydroxyvalerenic acid flavor usage levels up to | not for flavor use. |
No supplier data available
Potential Uses
Natural Occurrence
Synonyms
(2E)-3-[(1R,4S,7R,7aR)-1-
hydroxy-3,7-dimethyl-2,4,5,6,7,7a-hexahydro-1H-inden-4-yl]-2-methylacrylic acid
(2E)-3-[(1R,4S,7R,7aR)-1-
hydroxy-3,7-dimethyl-2,4,5,6,7,7a-hexahydro-1H-inden-4-yl]-2-methylprop-2-enoic acid
(E)-3-[(1R,4S,7R,7aR)-1-
hydroxy-3,7-dimethyl-2,4,5,6,7,7a-hexahydro-1H-inden-4-yl]-2-methylprop-2-enoic acid
2-
propenoic acid, 3-[(1R,4S,7R,7aR)-2,4,5,6,7,7a-hexahydro-1-hydroxy-3,7-dimethyl-1H-inden-4-yl]-2-methyl-, (2E)-
valerenic acid, hydroxy-
PubMed:
Pharmacokinetics of valerenic acid after single and multiple doses of valerian in older women.
PubMed:
Root colonization by symbiotic arbuscular mycorrhizal fungi increases sesquiterpenic acid concentrations in Valeriana officinalis L.
PubMed:
Transport of a GABAA receptor modulator and its derivatives from Valeriana officinalis L. s. l. across an in vitro cell culture model of the blood-brain barrier.
PubMed:
Preserved pharmacological activity of hepatocytes-treated extracts of valerian and St. John's wort.
PubMed:
In vitro activity of commercial valerian root extracts against human cytochrome P450 3A4.
PubMed:
Stability control of valerian ground material and extracts: a new HPLC-method for the routine quantification of valerenic acids and lignans.
PubMed:
Analysis of sesquiterpenes in Valeriana officinalis by capillary electrophoresis.
PubMed:
Cytotoxic potential of valerian constituents and valerian tinctures.